Dr. Rahim Karjoo, M.D., F.A.S.C.P. Offers Relief To The Legions Of Morgellons Patients
LOS ANGELES, Dec. 6, 2012 /PRNewswire/ -- Morgellons disease is a controversial topic. In many corners of the medical community, its very existence is dismissed as delusional ravings, though of course these declarations are usually couched in more polite terms. Nevertheless, using the word "psycho-somatic" instead of calling someone straight up crazy isn't all that much consolation to the people who are still suffering. The rise in Morgellons cases has given Dr. Rahim Karjoo renewed enthusiasm in his intensive research for a safe and effective Morgellons cure. His years of dedicated and meticulous investigation into the causality of Morgellons have borne fruit. Today, he is able to say with confidence that he has developed a treatment for people who report symptoms of Morgellons, otherwise known as "The Karjoo Phenomenon."
It seems fitting that this obscure condition, which so many have ignored for so long, should find new and deserved attention under a new name – the name of the one man who has never given up on the people who endure this terrible affliction. Dr. Karjoo's passionate pursuit of an answer for the question of Morgellons has led him to one inescapable conclusion: this is a malady that is exogenous in nature. More specifically, the culprit is silica, or silicone dioxide, pervasive now due to the increased use of cell phones, cosmetics, and other products found everywhere in modern, developed societies.
So…are you tired of being condescendingly dismissed by other "experts" who tell you it's all in your head? Are you close to giving up? Now is not the time to lose hope. Dr. Karjoo and his work represent a very real light at the end of the tunnel. Don't you owe it to yourself to give relief one last chance? The arc of medical discovery may be long, and often agonizingly slow, but it does get there eventually, and in the case of Morgellons, Dr. Karjoo has been in the vanguard of that movement all his professional life.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts